Epigral Ltd will convene on May 2, 2026, to assess their Q4 FY26 financial results and potentially propose a final dividend distribution for shareholders regarding their equity shares.

Epigral Ltd is scheduled to meet with institutional investors on April 8, 2026, in a non-deal roadshow hosted by Sunidhi Securities in Mumbai. The meeting aims to discuss the company's progress but will not disclose any undisclosed price-sensitive information.